ACPFG Blog

Swamped with saltwater: what a tsunami does to rice farmers

April 16, 2012

Filed under: Opinion — Tags: , — acpfg @ 4:07 pm

By Dr Darren Plett

Japan’s tsunami of March 11 2011 brought a wall of water laden with debris up to 5 kilometres inland from the sea. After the surge receded, the surrounding farming area was left covered in debris and a thick, black sludge. This sludge was extremely saline due to the sodium chloride from seawater.

Rice is the largest agricultural crop in Japan and the five prefectures affected by the 2011 tsunami are among the top producers of rice in Japan. Fortunately, less than 1.5% of Japan’s entire rice producing region was covered by the tsunami. Preliminary rice production statistics from the 2011 growing season show total rice production in Japan has hardly changed from 2010.

This all sounds fine on a national scale, but how did the tsunami affect the subsistence farmers in the tsunami-affected region? Reports indicate the 2011 rice production was severely decreased by salinity stress in the tsunami-affected region. This seriously affected the livelihood of these farmers. (more…)

Pretty wheat protein has biotechnology potential

March 13, 2012

Filed under: Research — Tags: , , , , — acpfg @ 11:08 am

A protein involved in moving lipids into wheat grains graces the cover of the Journal of Experimental Botany this month. Scientists at the Australian Centre for Plant Functional Genomics (ACPFG) discovered this protein, called TdPR61, while trying to find out how to express genes in the grain of wheat plants. The protein is expressed in specific parts of the grains of wheat, barley and rice, and it transports lipids (fats and oils). The new knowledge about where the gene is expressed can be used to improve grain quality or to increase the nutritional quality of grains. (more…)

Gene Patents

June 8, 2011

Filed under: Opinion — acpfg @ 2:01 pm

The very word “cancer” incites feelings of fear and dread; most of us do not understand where it comes from or why, the treatments seem unreliable and the outcomes are often miserable. Blocking gene patents is being supported by some cancer researchers because they are worried that access to critical information and materials will be stifled. They use emotive case studies to argue that somehow gene patents are inhibiting progress in curing patients. They are missing the point and surprisingly, as evidence based scientists, they are not applying the same techniques to critically examining the issues. There is little mention of the good outcomes that have been achieved using patented technologies. (more…)

Site designed by Arris Pty Ltd